9 November 2020 · There is very limited information on the use of corticosteroids during breastfeeding, although they are likely to be present in milk. Avoid prolonged high dose…
6 November 2020 · This updated Medicines Q&A is a quick reference summary to different types of enteral feeding tubes, in relation to medication issues. Not all enteral feeding…
29 September 2020 · This document is intended to support local discussions on how to monitor commonly prescribed high risk medicines in primary care. The monitoring parameters cited…
23 September 2020 · Topical corticosteroids are considered to pose a negligible risk to a breastfeeding infant as long as precautions are taken to avoid direct contact of the…
21 September 2020 · Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Aminosalicylates for chronic bowel disorders Mesalazine…
21 September 2020 · The use of oropharyngeal anti-inflammatories/analgesics is not considered to present any risk to a breastfeeding infant. Doxycycline is considered to present negligible risk when used…
17 September 2020 · Preparations for treating otitis externa have limited systemic absorption in the mother, and pose negligible risk to a breastfed infant. There is no published evidence…
29 May 2020 · Prednisolone 5mg orally is equivalent to hydrocortisone 20mg intravenously (equivalent anti-inflammatory dose). The peri-operative dose of hydrocortisone required may be higher than the equivalent prednisolone…
19 December 2019 · Alkindi® granules in capsules for opening is the first hydrocortisone product licensed solely for paediatric use for replacement therapy of adrenal insufficiency in infants, children and…
5 December 2019 · This Medicines Q&A gives guidance on dental procedures for which steroid supplementation may be required in patients with primary adrenal insufficiency and gives advice on…